关于 Vaxart, Inc.

Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. It was founded in 2004 by Sean Tucker. Originally incorporated as West Coast Biologicals, Inc. in California in 2004, the company later changed its name to Vaxart, Inc. in July 2007, after reincorporating in Delaware. A significant development in the company's history was the reverse merger with Aviragen Therapeutics, Inc. on February 13, 2018, which led to Vaxart becoming a wholly owned subsidiary of Aviragen. Post-merger, the company continued as Vaxart, Inc. Source: Wikipedia
行业Biological Products, (No Diagnostic Substances)
总部310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
成立2004
法律形式C Corporation
状态营业中

专利58 项专利

ANTIBODIES TARGETING GII GENOTYPES OF HUMAN NOROVIRUSWO2025255258A3 · 2026
ANTIBODIES TARGETING GII GENOTYPES OF HUMAN NOROVIRUSWO2025255258A2 · 2025
登录即可查看全部 58 项专利

浏览完整的专利组合,包括公开号、日期和同族专利。

登入 使用电子邮件创建账号

完全免费

在 Heelky 上搜索所有专利 →

评论

暂无评价。与 Vaxart, Inc. 合作过?来第一个分享你的经历吧。

撰写评价 →

关键数据

登录即可查看关键数据

Vaxart, Inc. 历年的营收、净利润和员工人数,并附数据来源。

登入 使用电子邮件创建账号

完全免费

联系方式和链接

地点

310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA

这是你的公司吗?

免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。

认领此页面

分享此公司

Vaxart, Inc.Biological Products, (No Diagnostic Substances)https://heelky.com/explore/companies/vaxart-inc-h88u74d0/

复制链接

分享到

二维码

用手机相机扫描即可打开此页面,也可以下载用于传单、幻灯片或胸牌。

加入 Heelky,建立联系、招聘人才、实现成长

创建免费账户,即可给他人发消息、申请职位并发布任务。

立即加入 — 完全免费

选择语言

Heelky 会记住你的选择。

其他语言

可用语言:70 关于 Heelky 的语言